Details for New Drug Application (NDA): 209731
✉ Email this page to a colleague
The generic ingredient in CLOVIQUE is trientine hydrochloride. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the trientine hydrochloride profile page.
Summary for 209731
| Tradename: | CLOVIQUE |
| Applicant: | Chartwell Rx |
| Ingredient: | trientine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 209731
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
| Approval Date: | Oct 21, 2019 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
